SFDM vs SPML vs SDR: A Side-by-Side Comparison of the Three Main Cerebral Palsy Surgeries
Parents researching surgical options for a child with spastic cerebral palsy encounter three acronyms repeatedly — SDR, SPML, and SFDM. Each represents a fundamentally different surgical approach, with different levels of invasiveness, different candidacy criteria, different recovery demands, and different outcomes. This guide breaks them down honestly, side by side, so you can arrive at your specialist consultation fully informed.
The three procedures at a glance
Before diving into the details, it helps to understand that these three procedures operate at three different anatomical levels: SDR works at the neurological level (the spinal cord), while SPML and SFDM work at the musculoskeletal level (the muscles and connective tissue). This fundamental distinction shapes everything about them — from who they help, to how long recovery takes, to what risks they carry.
What is SDR (Selective Dorsal Rhizotomy)?
Selective Dorsal Rhizotomy is a neurosurgical procedure first described in the 1970s and refined significantly at St. Louis Children’s Hospital under T.S. Park in the 1980s–1990s. It remains the most extensively studied surgical intervention for spastic diplegia in cerebral palsy.
How the procedure works
Under general anaesthesia, the neurosurgeon exposes the lumbar spine through a posterior midline incision (typically 5–8 cm) and performs a limited laminectomy — removing a small portion of vertebral bone — to access the lumbar nerve roots at the L1–S2 levels. Electrophysiological monitoring is used intraoperatively to test each dorsal nerve rootlet: those that generate abnormal, widespread reflex responses when electrically stimulated are selectively cut (rhizotomy). The goal is to reduce the hyperactive sensory drive to the spinal cord that sustains spasticity in the legs, while preserving the rootlets that maintain normal sensation and muscle function.
Who SDR is designed for
SDR is most effective in a well-defined, narrow patient profile:
- Children aged 3–8 years — the prime window for greatest benefit and lowest risk
- Spastic diplegia (both legs involved) as the dominant CP pattern
- Adequate baseline walking ability — the child should be independently ambulatory or close to it
- Pure spasticity, without significant dystonia or ataxia in the legs
- Normal or near-normal cognitive function to participate in intensive post-operative rehabilitation
- Sufficient core and trunk strength to sustain the demands of post-SDR therapy
- No significant pre-existing contractures — these are better addressed by orthopedic surgery
Important: SDR does not treat upper limb spasticity. Hands, wrists, elbows, and shoulders are not addressed by this procedure. Patients with spastic hemiplegia or quadriplegia involving the arms are generally not candidates for SDR as the primary intervention.
Rehabilitation after SDR
SDR requires the most demanding post-operative rehabilitation of any CP surgery. Because the procedure reduces muscle tone throughout the lower limbs — including in muscles that were being relied upon for support — patients typically experience a period of increased weakness immediately after surgery. An intensive physiotherapy program, typically lasting 12–24 months or more, is essential to rebuild strength, train new movement patterns, and convert the neurological benefit of reduced spasticity into functional walking improvement. Without this rehabilitation, the functional gains of SDR are substantially diminished.
What is SPML (Selective Percutaneous Myofascial Lengthening)?
Selective Percutaneous Myofascial Lengthening was developed by Dr. Roy Nuzzo as a minimally invasive alternative to traditional open tendon lengthening surgery for cerebral palsy. Where conventional tendon lengthening requires wide incisions and post-operative casting, SPML achieves similar musculoskeletal lengthening through a set of small percutaneous incisions.
How the procedure works
Under general anaesthesia or sedation, the surgeon uses specialized long, thin instruments inserted through several small skin incisions (typically 3–8 separate entry points per body segment) to selectively lengthen the myofascial junction — the transition zone between the muscle belly and its associated tendon or fascial sheath. By partially releasing this junction at multiple levels, the procedure allows the muscle-tendon unit to lengthen, reducing the mechanical tightness that limits joint range of motion and contributes to abnormal gait.
Unlike SDR, SPML operates entirely at the musculoskeletal level. It does not alter neurological function or change the intrinsic level of spasticity driving the muscle tightness — it addresses the structural consequence of that spasticity: the shortened, restricted muscle-tendon unit.
Who SPML is designed for
- Children and young adults with CP-related spasticity causing measurable restriction of joint range of motion
- Those with moderate contractures who would benefit from lengthening but are not appropriate for open surgery
- Patients who have had prior SDR and still present with residual lower limb tightness
- A useful adjunct procedure alongside other interventions
What is SFDM (Selective Fibrotomy of Damaged Muscles)?
Selective Fibrotomy of Damaged Muscles (SFDM) was developed by Professor Vigein Tovmasian at the CP Clinic in Vinnytsia, Ukraine, as an evolution of the minimally invasive orthopedic approach to CP spasticity. It builds on the same percutaneous, low-trauma philosophy as SPML but differs significantly in its anatomical target, comprehensiveness, and scope.
How the procedure works
Under general anaesthesia, typically within one hour, Professor Tovmasian performs up to 40 microincisions — each precisely 2–3 mm in diameter — targeting all affected muscle groups across the entire body simultaneously. Rather than targeting the myofascial junction as SPML does, SFDM targets the fibrotic tissue within the muscle belly itself — the scarred, damaged fibres that have formed in chronically spastic muscles and that restrict their ability to lengthen and function normally.
Each microincision is itself a microsurgical act — precisely locating and releasing only the pathological fibrotic tissue, leaving healthy muscle fibres intact. Because the incisions are 2–3 mm, no sutures are required, there are no visible scars, and patients are typically discharged within 12 hours of the procedure concluding.
The scope advantage: whole-body in one session
A distinguishing feature of SFDM is its capacity to address upper limbs, lower limbs, and the trunk simultaneously in a single operative session. For children with spastic quadriplegia or hemiplegia where arms and legs are both involved, this means a single surgery can comprehensively address the entire movement picture — rather than requiring staged procedures for different body segments.
Important distinction: SFDM and SPML share the minimally invasive percutaneous philosophy, but they target different tissues. SPML lengthens at the myofascial junction; SFDM selectively removes fibrotic tissue within the muscle belly itself using a higher number of precisely placed microincisions. This distinction matters both for the scope of what is achieved and for the recovery profile.
Full comparison table: SDR vs SPML vs SFDM
| Feature | SDR | SPML | SFDM |
|---|---|---|---|
| Surgical level | Neurosurgical (spinal cord) | Orthopaedic (myofascial) | Orthopaedic (muscle belly) |
| Invasiveness | Major surgery | Minimally invasive | Minimally invasive |
| Incision size | 5–8 cm spinal incision | Several small incisions (≈5–10 mm each) | Up to 40 × 2–3 mm microincisions |
| Sutures required | Yes (spinal + skin closure) | Sometimes (small adhesive closures) | No — incisions self-close |
| Hospital stay | 3–7 days post-op | 1–2 days | Same day (≤12 hrs) |
| Body segments treated | Lower limbs only | Lower limbs primarily | Full body — upper + lower limbs + trunk |
| Ideal age range | 3–8 years (strict) | 2+ years | 2+ years, no upper limit |
| CP type suited to | Spastic diplegia, ambulatory | Various patterns | All patterns including quadriplegia & hemiplegia |
| Rehabilitation duration | 12–24+ months intensive | Weeks to months | Weeks to months, home-based |
| Upper limb treatment | No | Limited | Yes — comprehensive |
| Reversibility | Irreversible (nerve cuts) | Irreversible (structural) | Irreversible (structural) |
| Risk of neurological side effects | Yes — sensory loss, bladder, weakness | Minimal | Minimal |
| Reported success rate | Variable (80–90% functional improvement with proper rehab) | Variable (centre-dependent) | 98% (CP Clinic outcomes) |
| International patients | Major centres only (US, UK, Australia) | Limited specialist centres | Yes — telemedicine evaluation, 4–5 day total stay |
8-dimension analysis: what really separates these procedures
1. Anatomical level — where each surgery intervenes
This is the most fundamental distinction. SDR intervenes at the neurological level, permanently altering the sensory nerve pathways that feed into spinal cord reflexes. The spasticity reduction it produces is therefore neurological in origin. SPML and SFDM intervene at the musculoskeletal level — they modify the mechanical properties of the muscles and surrounding tissue, allowing them to lengthen and function more normally despite the neurological spasticity that remains. Neither SPML nor SFDM changes the brain injury or the underlying neurological drive of spasticity; they address its physical manifestation in the tissues.
2. Invasiveness and surgical risk
SDR carries the risks of any major spinal neurosurgery. These include persistent altered sensation in the legs or perineum (reported in 5–15% of cases in various series), bladder and bowel dysfunction, the risk of spinal instability, a small risk of progression of scoliosis, and the risks of general anaesthesia for a longer operative period. SPML and SFDM carry a significantly lower risk profile. SFDM specifically, with its 2–3 mm microincisions requiring no sutures, has an extremely low complication rate and rapid return to baseline activity.
3. Who can be treated — candidacy
SDR’s candidacy criteria are deliberately narrow. Offering SDR to children with significant dystonia, weak trunk and core muscles, pre-existing contractures, or quadriplegic involvement generally produces poor outcomes and is contraindicated. SFDM has significantly broader candidacy — it is applicable to all patterns of spastic CP (diplegia, hemiplegia, quadriplegia), to children from age 2, and to adults of any age with no upper age limit. This breadth makes SFDM suitable for many patients who are not candidates for SDR.
4. Which body segments are addressed
SDR targets the lumbar nerve roots and exclusively reduces spasticity in the lower limbs. It offers nothing for arm and hand spasticity. SPML can be applied to both upper and lower limb regions, though it is most commonly used for the lower limbs and hip musculature. SFDM addresses all affected muscle groups throughout the entire body in a single surgical session — including hands, wrists, forearms, shoulders, hips, thighs, calves, and feet — making it uniquely comprehensive for patients with whole-body involvement.
5. Recovery and rehabilitation demands
SDR’s recovery is the most demanding. The immediate post-operative period involves greater pain management needs, and the rehabilitation commitment is substantial — typically 5 days per week of intensive physiotherapy for the first 6–12 months, then gradually reducing over 1–2 additional years. This is a significant burden on families. SFDM patients begin gentle rehabilitation within days of surgery and follow a home-based program — this is particularly practical for international families who travel to Ukraine for the procedure.
6. Permanence and reversibility
All three procedures produce long-lasting changes that are not reversible. SDR is neurologically irreversible — the severed nerve rootlets do not regenerate. Both SPML and SFDM produce structural changes to the muscles and connective tissue. None of this implies a second surgery is impossible if residual issues persist — indeed, SFDM can be performed after prior SDR or SPML if residual contracture or upper limb involvement requires additional treatment.
7. Age of treatment
SDR has a relatively tight age window — most evidence supports the best outcomes between 3 and 8 years, with the procedure rarely performed outside this range. SPML and SFDM are more flexible. SFDM specifically is performed from 24 months of age with no upper age limit. This makes SFDM an option for young toddlers who cannot yet undergo SDR, for older children who missed the SDR window, and for adults who were not diagnosed or did not have access to surgical intervention as children.
8. Accessibility and logistics for international families
SDR is available at a limited number of highly specialized neurosurgical centres worldwide — principally in the United States (St. Louis, Chicago), the United Kingdom (Great Ormond Street, Bristol), and Australia. Access can involve long waiting lists and substantial costs. The CP Clinic in Vinnytsia, Ukraine offers SFDM to international patients through a telemedicine pre-assessment process, a 4–5 day total stay at the clinic, and a home-based rehabilitation program. This reduces the logistical burden significantly for families travelling from abroad.
Which surgery is right for your child — or for you?
There is no universally “best” CP surgery. The right choice depends on the specific patient profile, the pattern and severity of involvement, the patient’s age, and the goals of treatment. Below is a general framework — always confirmed by specialist evaluation.
- Child is 3–8 years old
- Spastic diplegia (legs primarily)
- Child can walk independently or nearly so
- No significant upper limb involvement
- Minimal contractures already present
- Family can commit to 12–24 months of intensive therapy
- Pure spasticity — no significant dystonia
- Moderate contractures in specific muscle groups
- Lower limb involvement, limited upper limb needs
- Previous SDR with residual tightness
- Seeking minimally invasive option before major surgery
- Specialist centre with SPML experience accessible
- Age 2+ or adult (any age)
- Any CP pattern — diplegia, hemiplegia, quadriplegia
- Upper and lower limbs both involved
- Outside the SDR age window
- Family needs a shorter, home-based rehab program
- International patient seeking a single short-stay option
- Previous surgery with residual issues to address
Can a patient have more than one of these surgeries? Yes. SFDM and SDR address spasticity at different anatomical levels and are not mutually exclusive. Some patients undergo SDR for lower limb neurological spasticity and later receive SFDM for residual muscle contractures or upper limb involvement that SDR did not address. A specialist evaluation is necessary to determine the optimal sequence and combination for each individual case.
Unsure which surgery is right for your child? Our team can evaluate your case remotely via telemedicine — no travel required for the initial consultation.
Request a free evaluation →Frequently asked questions
What is the difference between SFDM, SPML, and SDR?
SDR (Selective Dorsal Rhizotomy) is a neurosurgical procedure that permanently reduces spasticity by cutting specific sensory nerve rootlets in the lumbar spinal cord — it operates at the neurological level. SPML (Selective Percutaneous Myofascial Lengthening) is a minimally invasive orthopedic procedure that lengthens the muscle-fascia units through small percutaneous incisions. SFDM (Selective Fibrotomy of Damaged Muscles) is a further evolution of the minimally invasive approach, addressing the fibrotic tissue within spastic muscle bellies through up to 40 microincisions of 2–3 mm, covering all body segments simultaneously in a single session.
Is SDR better than SFDM for cerebral palsy?
SDR and SFDM address spasticity at different anatomical levels and suit different patient profiles. SDR is best for ambulatory children aged 3–8 with spastic diplegia who can participate in years of intensive post-operative rehabilitation. SFDM is minimally invasive, suited from age 2 with no upper limit, covers all body segments in a single session, and international patients return home within 4–5 days. The best choice depends entirely on the individual patient and should be determined by specialist evaluation.
Can a child have SFDM surgery after already having SDR?
Yes. SFDM operates at the muscular level and does not interfere with prior spinal surgery. Children who have undergone SDR and still present with residual muscle contractures or upper limb spasticity that SDR did not address are often suitable candidates for subsequent SFDM. A specialist evaluation is required to assess the specific residual presentation.
What is SPML surgery and how does it differ from SFDM?
SPML, developed by Dr. Roy Nuzzo, uses small percutaneous instruments to lengthen the myofascial junction — the transition zone between muscle and tendon — through a series of small incisions. SFDM, developed by Professor Vigein Tovmasian, targets the fibrotic tissue within the muscle belly itself, uses up to 40 microincisions of only 2–3 mm, and is designed to simultaneously treat all affected muscle groups across both upper and lower body in one surgical session.
At what age is each CP surgery performed?
SDR is typically performed between 3 and 8 years — outside this window, outcomes are generally less optimal. SPML can begin from around 2 years of age. SFDM can also be performed from 24 months with no maximum age limit — patients up to nearly 60 years old have undergone SFDM at the CP Clinic with meaningful outcomes.
How long is recovery after each type of CP surgery?
SDR requires 5–7 days in hospital and an intensive physiotherapy program lasting 12–24 months or more. SPML patients return home within 1–2 days; rehabilitation lasts weeks to a few months. SFDM patients are discharged the same day, can begin upper limb rehabilitation within 2–3 days and lower limb rehabilitation within 7–8 days, and international patients spend 4–5 days total at the CP Clinic before returning home.
Does SDR work on the arms and hands as well as the legs?
No — SDR targets the L1–S2 lumbar nerve rootlets and addresses lower limb spasticity only. It does not treat upper limb spasticity in the hands, wrists, elbows, or shoulders. SFDM, by contrast, addresses all affected muscle groups throughout the body including the upper limbs in the same single surgical session, making it a more comprehensive single-session option for patients with whole-body involvement.
Which CP surgery has the fewest risks and complications?
SFDM and SPML carry a significantly lower risk profile than SDR because they do not involve the spinal cord or nerve roots. SDR risks include persistent sensory changes, bladder and bowel dysfunction, spinal instability, scoliosis progression, and — rarely — lower limb weakness. SFDM, with its 2–3 mm microincisions and same-day discharge, has a minimal complication profile. No surgery is entirely risk-free; any surgical decision should be made in consultation with a qualified specialist.
References and clinical sources
- Park TS, et al. (2006). “Selective dorsal rhizotomy: 20 years’ experience.” Seminars in Pediatric Neurology. PubMed ↗
- Tedroff K, et al. (2018). “Long-term effects of selective dorsal rhizotomy in children with cerebral palsy: a systematic review.” Developmental Medicine & Child Neurology. PubMed ↗
- Grunt S, et al. (2011). “Indications and outcome of selective dorsal rhizotomy in children with spastic cerebral palsy.” Developmental Medicine & Child Neurology. PubMed ↗
- Nuzzo R. (2020). “Selective Percutaneous Myofascial Lengthening.” PMC, National Library of Medicine. PMC ↗
- Novak I, et al. (2020). “State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy.” Current Neurology and Neuroscience Reports. PubMed ↗
- Graham HK, et al. (2000). “Multilevel orthopaedic surgery in group IV spastic hemiplegia.” Journal of Bone and Joint Surgery (British). PubMed ↗